Safety and Immunogenicity Study of Recombinant Modified Vaccinia Virus Ankara (MVA) Virus to Treat HIV Infection

This study has been completed.
Sponsor:
Information provided by:
Bavarian Nordic
ClinicalTrials.gov Identifier:
NCT00386633
First received: October 9, 2006
Last updated: December 21, 2007
Last verified: December 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2007
  Estimated Primary Completion Date: No date given